Literature DB >> 24778127

Response to letter regarding article, "High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy".

Samia Mora1, Robert J Glynn, Paul M Ridker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24778127      PMCID: PMC4584403          DOI: 10.1161/CIRCULATIONAHA.114.009345

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges.

Authors:  Robert S Rosenson; H Bryan Brewer; Benjamin Ansell; Philip Barter; M John Chapman; Jay W Heinecke; Anatol Kontush; Alan R Tall; Nancy R Webb
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

2.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

3.  High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy.

Authors:  Samia Mora; Robert J Glynn; Paul M Ridker
Journal:  Circulation       Date:  2013-09-03       Impact factor: 29.690

Review 4.  Unraveling the complexities of the HDL lipidome.

Authors:  Anatol Kontush; Marie Lhomme; M John Chapman
Journal:  J Lipid Res       Date:  2013-03-30       Impact factor: 5.922

5.  HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.

Authors:  Paul M Ridker; Jacques Genest; S Matthijs Boekholdt; Peter Libby; Antonio M Gotto; Børge G Nordestgaard; Samia Mora; Jean G MacFadyen; Robert J Glynn; John J P Kastelein
Journal:  Lancet       Date:  2010-07-23       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.